Skip to main content
Premium Trial:

Request an Annual Quote

Willim Stemmer, Nina Siegler, Alexander Bondar

Premium

Willim Stemmer has joined the scientific advisory board of Copenhagen, Denmark-based Nuevolution. Stemmer is the founder of Maygen, Avidia, and Genetic Designs, and previously worked at Affymax Research Institute, as well as Hybritech. Stemmer holds a PhD from the University of Wisconsin-Madison.


Nina Siegler was named managing director of life sciences for the Bethesda, Md.-based investment bank, National Capital. Siegler was an equities analyst for such companies as Paine Webber and Prudential Bache and also worked at the National Institutes of Health and the office of technology transfer at Johns Hopkins University. She holds an MBA from the University of Virginia, and a BS in biology from the University of North Carolina.


Alexander Bondar was named executive director for biotechnology business development for Jupiter, Fla.–based Dyadic, an industrial enzyme maker that now offers gene and protein research services. Bondar previously was employed in the life sciences group of the Aurora Funds, a Research Triangle Park, NC-based venture capital firm. He holds an MBA from Duke University.

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.